Oliver Luxxe Assets’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,820
Closed -$218K 129
2020
Q1
$218K Buy
5,820
+231
+4% +$9.84K 0.14% 109
2019
Q4
$255K Sell
5,589
-1,309
-19% -$51.9K 0.13% 111
2019
Q3
$244K Buy
6,898
+460
+7% +$17.1K 0.14% 106
2019
Q2
$252K Buy
6,438
+19
+0.3% +$747 0.14% 108
2019
Q1
$267K Buy
6,419
+306
+5% +$12.4K 0.15% 102
2018
Q4
$224K Buy
6,113
+886
+17% +$37.8K 0.15% 94
2018
Q3
$240K Buy
+5,227
New +$248K 0.14% 93
2018
Q1
Sell
-23,935
Closed -$1.04M 103
2017
Q4
$1.04M Buy
23,935
+1,280
+6% +$54.4K 0.63% 46
2017
Q3
$964K Buy
+22,655
New +$961K 0.61% 47

Other funds holding XPH